Yorkshire tech firm Siguru seals second seed fundraise to help prepare for growth

Siguru, which was founded by entrepreneurs Dan Bentley and Harry Bliss, is developing its AI system for medical, legal, and regulatory affairs review in the pharmaceutical sector

A Yorkshire tech company has sealed additional funding to help develop its AI system and gear up for growth. Sheffield-founded tech business Siguru Ltd has secured the undisclosed funding amount to continue working on its AI system for medical, legal, and regulatory affairs review in the pharmaceutical sector, and to validate market demand.

The entrepreneurs are raising funds via carefully selected angel investors, friends, family and industry contacts to develop the business. This marked the second external fundraising round for the company, after Sheffield-based Wake Smith handled the legals for its first fundraise.

Tom Haywood and Aaron Patel in Wake Smith Solicitors’ company and commercial team acted for Siguru, which was founded by entrepreneurs Dan Bentley and Harry Bliss in May 2025.

Mr Haywood said: “These two rounds of funding confirm a healthy appetite for investment into the right companies at all levels and supports the North’s burgeoning AI market.

“People invest in companies, but, just as importantly, founders and this investment is an endorsement of their work in the creation of market-leading, innovative products.

“The investors bring together variety of interests and skills – from tech, business, medicine and pharma to work on a really exciting product and we look forward to seeing how it develops”

Mr Bliss said: “We are an ambitious, high tech company at the forefront of AI technology-based systems. Our products can be used by marketing and commercial teams, medical affairs and governance, digital teams, and leadership – anywhere approval speed and compliance both matter. The thriving online market offers high opportunities for growth.

“Our AI platform supports pharma marketing and medical teams through the MLR process – aiming to reduce approval timelines from 40 days to a week.

“Further development of the products and business through the funding will move us towards a commercial launch with the hiring of employees and improvements on a minimum viable product.

“Siguru will expand through developing partnerships and go-to-market, working closely with medical and compliance leaders to build for real-world pharma workflows. We look forward to our journey with Wake Smith Solicitors advising us along the way.”